1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. PI3K
  4. PI3K Antagonist

PI3K Antagonist

PI3K Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-124615
    ST-162
    Antagonist
    ST-162 is a MAPK/PI3K dual antagonist. ST-162 exhibits antitumor activity and can increase the efficacy of immune checkpoint blockers. ST-162 can be used for the research of cancer, such as melanoma.